Current Trials

At Cleaver Medical Group, our dermatologists, Dr. Nathan Cleaver and Dr. Weston Waxweiler, are deeply committed to clinical research. They strongly believe that research is not only vital to advancing healthcare but also to improving the lives of our patients. Through research, we aim to offer our patients access to innovative treatments that may not be otherwise available, allowing us to provide cutting-edge care and play an active role in shaping the future of dermatology.

Cleaver Medical Group is currently enrolling participants for the following studies:

Atopic Dermatitis:

- Adults 18 years of age and older who are currently experiencing an inadequate response to their current treatment.

- Open-label study for adults 18 years and older who are currently on Dupixent and having an inadequate response.

- Adolescents 12-17 years of age currently experiencing minimal to no improvement with their current topical therapy.

- Children 6-11 years of age who have not seen improvement from previous atopic dermatitis treatment.

Vitiligo:

- Adults 18 years of age and older with non-segmental vitiligo using a once daily oral medication

Alopecia Areata:

- Adults 18-64 years of age with severe patchy hair loss for a trial using an investigational drug in achieving hair regrowth.

Hidradenitis Suppurativa (HS):

- Adults aged 18 and older and haven’t seen improvement from a previous HS treatment.

If you or someone you know may be interested in participating please call 770-800-3455 ex 1014 or 770-746-6369 for the research department. The research staff can answer any questions you have and see if you may qualify for the trial.

Cleaver Medical Group Dermatology

✆ Phone (General): 770-800-3455

✆ Phone (Appointments): 770-800-3455

Fax: 770-450-8024

Address: 105 Professional Park Drive, Cumming, GA 30040

4.88

Medical Websites Powered by TEBRA